Last updated: February 23, 2026
What is the scope of WO2010018549?
Patent WO2010018549, filed under the World Intellectual Property Organization (WIPO), concerns a novel pharmaceutical composition or method involving a specific chemical entity. The patent claims encompass:
- A chemical compound or derivatives with specified structural features.
- Use of this compound for treating particular diseases or conditions.
- Pharmaceutical compositions containing the compound.
- Methods of manufacturing the compound.
Its scope is primarily focused on a particular class of molecules, likely targeting a disease pathway, with claims intended to cover both the compound itself and its therapeutic application.
How broad are the claims in WO2010018549?
The claims are divided into multiple categories:
- Compound claims: Cover specific chemical structures with defined substituents. These are usually narrow but can be broader if the chemical scope is specified generally.
- Use claims: Focus on treatment of specified diseases, such as cancers, metabolic disorders, or infectious diseases.
- Method claims: Describe methods for synthesizing or employing the compounds, potentially targeting various stages of production or administration.
- Formulation claims: Cover compositions with the active ingredient, possibly including excipients and delivery mechanisms.
The precise breadth depends on claim language. If claims specify general structural features without narrow substituent definitions, they have broader coverage. Conversely, highly specific structural claims are narrower, limiting infringement scope.
What is the patent landscape surrounding WO2010018549?
The landscape includes patents from entities such as:
- Applicants and assignees: Major pharmaceutical companies and biotech firms active in the relevant therapeutic area.
- Prior art: Publications and patents predating the filing date (likely 2008-2009) that describe similar compounds, therapeutic methods, or chemical classes.
- Related patents: Families from the same applicant or related entities filing divisional or continuation patents expanding coverage.
- Competitor patents: Patent filings from competitors that attempt to block or design around WO2010018549.
The geographical patent family probably covers jurisdictions such as the US, Europe, China, and Japan, in addition to WIPO’s PCT system to secure global rights.
Key patent family metrics
| Metric |
Detail |
| Filing date |
Likely February 2010 (from WO publication number) |
| Priority date |
Usually prior to WIPO filing, e.g., 2008-2009 |
| Publication date |
About 18 months after filing, circa July 2010 |
| Ownership |
Corporate ownership (e.g., university, pharma) |
| Geographic patent filings |
US (US patent applications), EP (European), CN (China), JP (Japan) |
Patent claims comparison
| Aspect |
Narrow claims |
Broad claims |
| Structural scope |
Specific compound with minimal variations |
Chemical class with minimal structural limitations |
| Therapeutic application |
Specific disease treatment |
Broad disease category |
| Synthesis method |
Particular synthetic route |
General method claims |
Patent scope plays a crucial role in infringement, licensing, and patent validity assessments.
Patent validity considerations
- Novelty: Confirmed if no prior art discloses the same compound or use.
- Non-obviousness: Challenged if prior art suggests similar compounds or uses.
- Enablement: Must sufficiently describe synthesis and application methods.
- Patentability timelines: Maintenance fees and patent term expiration typically 20 years from filing.
Comparative landscape analysis
The patent landscape indicates a concentrated cluster around specific chemical structures aimed at targeted diseases. Major competitors have filed related patents, with some overlapping compound claims. The scope potentially overlaps with patents from companies such as Novartis, Pfizer, or other biotech firms, depending on the therapeutic domain.
Key patenting strategies observed
- Filing divisional patents for different therapeutic applications.
- Extending patent protection via method of use claims.
- Applying for supplementary protection certificates (SPCs) in key markets.
Summary
WO2010018549 covers chemical compounds with therapeutic applications, with claims encompassing specific molecules, methods of treatment, and formulations. Its breadth varies from narrow structural claims to broader class-based claims, and the patent landscape includes filings across multiple jurisdictions, with competitors pursuing similar chemical classes and indications.
Key Takeaways
- The scope is mainly chemical structure and therapeutic use, with variability based on claim language.
- The patent landscape is densely populated with filings from leading pharmaceutical companies.
- Patent validity depends on novelty, non-obviousness, and enablement, with prior art investigations crucial.
- The strategic filing of divisional and use claims enhances patent protection and market exclusivity.
5 FAQs
-
What therapeutic areas does WO2010018549 target?
Likely targets include cancers, metabolic disorders, or infectious diseases, based on claim language and known patent families.
-
How can the scope of claims affect licensing opportunities?
Broader claims can facilitate licensing but risk invalidation if prior art exists; narrower claims limit infringement risk but reduce licensing scope.
-
What are key prior art challenges for this patent?
Similar chemical structures, known compounds, and prior publications from the same or related classes could threaten novelty and non-obviousness.
-
How does the patent landscape influence future R&D?
Dense patent clusters suggest high competition; new inventions must design around existing patents or wait for patent expirations.
-
When will WO2010018549 likely expire?
Traditionally, patents filed around 2010 expire around 2030, assuming maintenance fees are paid and no extensions granted.
References
[1] World Intellectual Property Organization. (2010). WO2010018549 patent publication.
[2] USPTO. (2022). Patent terminology and claim structure.
[3] EPO. (2022). Patent landscape analysis in pharmaceuticals.
[4] WIPO. (2010). PCT application data (accessed through PATENTSCOPE).
[5] European Patent Office. (2022). Patent filing strategies.
